These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11675851)

  • 21. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
    Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient.
    Conus P; Bondolfi G; Eap CB; Macciardi F; Baumann P
    Pharmacopsychiatry; 1996 May; 29(3):108-10. PubMed ID: 8738315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic and toxic concentrations of mirtazapine.
    Kirkton C; McIntyre IM
    J Anal Toxicol; 2006; 30(9):687-91. PubMed ID: 17137530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotransmitters in depression: noradrenaline and serotonin and their interactions.
    Leonard BE
    J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():1S. PubMed ID: 9090572
    [No Abstract]   [Full Text] [Related]  

  • 25. First report of mirtazapine overdose.
    Hoes MJ; Zeijpveld JH
    Int Clin Psychopharmacol; 1996 Jun; 11(2):147. PubMed ID: 8803652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
    Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
    J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
    Deuschle M; Angermeier T; Westphal S; Lederbogen F; Gilles M; Frankhauser P; Schilling C; Onken V; Weber-Hamann B; Kopf D
    Psychother Psychosom; 2010; 79(2):123-5. PubMed ID: 20090399
    [No Abstract]   [Full Text] [Related]  

  • 28. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mirtazapine: a newer antidepressant.
    Hartmann PM
    Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease.
    Nagata T; Shinagawa S; Tagai K; Nakayama K
    Int Psychogeriatr; 2013 Jul; 25(7):1199-201. PubMed ID: 23195073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mirtazapine, but not fluvoxamine, normalizes the blunted REM sleep response to clonidine in depressed patients: implications for subsensitivity of alpha(2)-adrenergic receptors in depression.
    Schittecatte M; Dumont F; Machowski R; Fontaine E; Cornil C; Mendlewicz J; Wilmotte J
    Psychiatry Res; 2002 Jan; 109(1):1-8. PubMed ID: 11850045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mirtazapine--the new standard].
    Fortschr Neurol Psychiatr; 1999 Aug; 67(8 Suppl):1-4. PubMed ID: 10511867
    [No Abstract]   [Full Text] [Related]  

  • 33. [A Case with the Increased PT-INR after the Addition of Mirtazapine to Warfarin Therapy].
    Nishimura H; Kawakami M
    Seishin Shinkeigaku Zasshi; 2015; 117(10):820-5. PubMed ID: 26827407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertriglyceridemia, acute pancreatitis, and diabetic ketoacidosis possibly associated with mirtazapine therapy: a case report.
    Chen JL; Spinowitz N; Karwa M
    Pharmacotherapy; 2003 Jul; 23(7):940-4. PubMed ID: 12885107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion.
    Jagsch C; Marksteiner J; Seiringer E; Windhager E
    Pharmacopsychiatry; 2007 May; 40(3):129-31. PubMed ID: 17541890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmentative effects of fluvoxamine on duloxetine plasma levels in depressed patients.
    Paulzen M; Finkelmeyer A; Grözinger M
    Pharmacopsychiatry; 2011 Nov; 44(7):317-23. PubMed ID: 21979923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
    Normann C; Hesslinger B; Frauenknecht S; Berger M; Walden J
    Pharmacopsychiatry; 1997 Nov; 30(6):263-5. PubMed ID: 9442549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First report of mirtazapine-induced arthralgia.
    Jolliet P; Veyrac G; Bourin M
    Eur Psychiatry; 2001 Dec; 16(8):503-5. PubMed ID: 11777743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mirtazapine as treatment for serotonin syndrome.
    Hoes MJ; Zeijpveld JH
    Pharmacopsychiatry; 1996 Mar; 29(2):81. PubMed ID: 8741027
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.